Press release -
Osstell expand the number of global partners with MPM Wholesale Supplies Ltd as their exclusive distributor in the UK
Osstell strengthens its UK presence even further with the renewal of MPM's partnership and also announces that Neoss has been appointed by Osstell and MPM as an authorized UK dealer solely for their Neoss implant customers. MPM will represent Osstell as they develop the UK market, with a major focus on serving customer needs. Osstell views the UK as an upcoming market with a healthy expected growth together with MPM.
“MPM is a young company with forward looking visions and a hard-working team. We will jointly promote and support the instrument platform, the Osstell ISQ, and work towards a growing, more demanding market, which can now be met with a safer and more professional approach in implant treatment. Choosing surgical and restorative protocols can and should be done objectively and scientifically with the Osstell ISQ, especially when it comes to reducing treatment time and to manage implants at risk. MPM now has the tool to help all implant-treating dentists with just that." says Andreas Danielsson, Export Sales Manager, Osstell AB.
Topics
- Business enterprise
Categories
- implant stability
- implant stability quotient
- isq
- osstell
- osstell isq
- ostell
- resonans frequency analysis
- rfa
20 years ago two scientists shared the frustration of not being able to monitor osseointegration in an accurate, objective and consistent way – beyond their own dexterity and tactile skills. The concept of Resonance Frequency Analysis was developed.
The technique has since then been documented in 500 scientific publications and adopted by > 8 000 clinicians worldwide – becoming a global standard in implant treatment.
All Osstell employees are personally committed to the worldwide adoption of our unique diagnostics technique and to the success of our company. To succeed, we make sure our customers get the unrelenting support and service they deserve
